PTPrasad Thota

Prasad Thota

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Prasad Thota has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Anusha Thota

    Department of Global Pharmacovigilance, Sun Pharmaceuticals Pvt. Ltd., Gurugram, Haryana, India

    4 shared publications
  • Bikash Medhi

    Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    3 shared publications
  • Gyanendra Nath Singh

    Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India

    2 shared publications
  • Kalaiselvan Vivekanandan

    National Coordination Centre-Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh

    2 shared publications
  • Phulen Sarma

    Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    2 shared publications
  • Shabir Sidhu

    Department of Life Sciences, IKG-Punjab Technical University, Jalandhar, Punjab

    2 shared publications

Latest Publications

  • Open Access

    Microbiological quality control of non-sterile pediatric pharmaceutical products

    by Deeksha Verma, Anil Kumar Teotia, Sanjay Mendiratta, Prasad Thota, Manoj Pandey, Vivekanandan Kalaiselvan

    Pharmaceutical pediatric products—whether sterile or non-sterile—must meet the relevant microbiological quality standards to ensure safety and efficacy. During production and use, many pharmaceutical pediatric products are vulnerable to contamination from a wide range of microbial species. Young children under 5 years of age and infants are particularly vulnerable to harmful and accidental infections due to their immature immune systems and limited prior exposure to antigens. When these young children consume pharmaceutical preparations of inadequate microbiological quality, they may be exposed to serious health risks. Maintaining the safety and efficacy of non-sterile pediatric pharmaceutical products, as well as safeguarding children’s health, depends on their microbiological quality. Pharmaceutical pediatric products are widely used in India; therefore, it is essential to assess their microbiological quality and overall safety. This study examines the microbiological quality of 26 pediatric drug products. Using compendial methods, the pediatric drug products were analyzed for the presence of specified microorganisms, total yeast and mold count, and total aerobic microbial count. Based on the study’s findings, three of the pediatric drug products showed microbial contamination levels above the maximum acceptable limits specified in the Indian Pharmacopoeia. The pediatric drug products under examination did not contain the specified microorganisms, including Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. It is advised that current good manufacturing practices and appropriate hygiene measures be strictly followed when manufacturing, handling, and dispensing these products; therefore, microbial quality control is crucial to prevent contaminated products from reaching the market and to protect public health.

  • Open Access

    A Comparative Study of Pharmacopoeial Quality Standards and Regulations of Radiopharmaceuticals

    by Prasad Thota, Anusha Thota, Manoj Kumar Pandey, Phulen Sarma, Bikash Medhi, Rakesh Kumar Sharma, Jai Prakash, Anil Kumar Teotia

    Radiopharmaceutical preparations are the important pharmaceutical dosage forms used for the diagnosis and therapeutic purposes. Various pharmacopoeias are having methods for the quality control of these preparations in the form of monographs. Indian Pharmacopoeia (IP) also included these monographs in IP 2014 first time with the help of an experts' group on radiopharmaceutical, drawing expertise from elite stakeholder institutions and the core team of Indian Pharmacopoeia Commission. Since then, these standards are regularly updated through the IP addendum and bringing out new edition of IP. IP is a book of official methods as per Drugs and Cosmetic Act, 1940. These standards can be used in government laboratories, private laboratories, or academia in India and abroad. This review provides an overview of the journey of radiopharmaceuticals' standard setting in IP. A comprehensive comparative information of regulatory perspectives of radiopharmaceuticals in different jurisdictions such as the US, EU, and India is also presented.


  • Therapeutic options for management of Hori's nevus: A systematic review

    by Harpinder Kaur, Phulen Sarma, Sukhmandeep Kaur, Hardeep Kaur, Manisha Prajapat, Saniya Mahendiratta, Subodh Kumar, Prasad Thota, Davinder Parsad, Bikash Medhi

    Introduction Hori's nevus is a pigmentation disorder reported mainly in middle‐aged Asian women. There is no systematic review addressing its pharmacotherapy. Materials and methods The population for our systematic review was patients with a clinical/ histological diagnosis of Hori's nevus (both sex, any age group). We screened 5 literature databases using relevant keywords. All RCTs, observational studies and case series mentioning at least one intervention and outcome of that intervention were included. Result 19 studies were included in the final systematic review from total 680 identified non‐duplicate records. Different forms of laser[alexandrite laser (QSAL and PSAL), Nd:YAG laser (QSNYL high fluence, low fluence, 532 followed by 1064 nm), Er: YAG and Nd:YAG combination, ruby laser (QSRL), CO2 laser followed by QSRL] and dermabrasion were found to be useful in treatment of Hori' nevus. Conclusion Among alexandrite lasers, PSAL is more efficacious and safe than QSAL.In case of high fluence QSNYL, hyperpigmentation rate is quite high while low fluence QSNYLrequires morenumber of treatment sessions. The combined 1064nm + 532 nm protocol is better in terms of efficacy and safety. Er:YAG + Nd:YAG combination have similar efficacy and added advantage of synergistic action and no adverse event.


  • Open Access

    Targeted Spontaneous Reporting on Drug Safety Alerts Issued by Pharmacovigilance Programme of India: A New Origin of Pharmacovigilance in India

    by Prasad Thota, Shabir Sidhu, Bikash Medhi, Phulen Sarma, Ajay Prakash, Kalaiselvan Vivekanandan, Anusha Thota

  • Open Access

    Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India

    by Prasad Thota, Vijit Agrawal, Tarani Prakash Shrivastava, Pramod Kumar Adusumilli, Kalaiselvan Vivekanandan, Shashi Bhushan

    Misuse of antimicrobials has become one of the grave concerns of public health. In last two decades, this has been largely contributing in the emergence of antimicrobial resistance (AMR) among all the pathogens. A 2013 report of Centres for Disease Control and Prevention, USA figured that at least 2 million people get an antibiotic-resistant infection every year and as many as 23,000 people lost their life. A multi-country survey in Southeast Asia region conducted by World Health Organization (WHO) in 2015, identified several gaps in knowledge and awareness about the optimal use of antimicrobials and AMR. Following this, the Ministry of Health and Family Welfare (MoHFW), Government of India, developed National Action Plan in the year 2017 to combat AMR. Pharmacovigilance Programme of India (PvPI) being a flagship programme of MoHFW holds the responsibility of ensuring safety of medicines used by India population and has recently identified AMR as one of the strategic priorities. This article intends to provide insights of the recent attempts and deliberate efforts made by PvPI in the containment of AMR in India and it also intends to sensitize healthcare fraternity on restricting AMR in public interest.


  • Open Access

    Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India

    by Prasad Thota, Anusha Thota, Bikash Medhi, Shabir Sidhu, Pramod Kumar, V Kalai Selvan, Gyanendra Nath Singh

    Background: The National Coordination Centre-Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission works under the aegis of Ministry of Health and Family Welfare, Government of India. It promotes patient safety in India and also supports postmarketing surveillance programs. Currently, almost hundred thousand case reports are submitted to NCC-PvPI each year through its 250 ADR Monitoring Centers (AMCs) located across India, and India is the one of the top ten contributor countries under WHO-Uppsala Monitoring Centre since 2012 and start issuing drug safety alerts from March 2016. Aim: This study aims to highlight the drug safety alerts issued by NCC-PvPI from March 2016 to June 2017 and urgent need for further monitoring by adopting targeted spontaneous reporting (TSR) methodology at AMCs and its impact on the NCC's drug safety database, i.e., VigiFlow in India. Methodology: A retrospective analysis was done for the reported unlisted ADRs by various AMCs to PvPI through VigiFlow, i.e., individual case safety report (ICSR) management system at NCC, where these unlisted drug-ADR combinations considered and issued as drug safety alerts for further reporting these to NCC, if any detected at healthcare settings during routine clinical practice by healthcare professionals. Results: From July 2011 to June 2017, NCC-PvPI was collated 250,787 ICSRs and contributed to WHO international drug safety database, i.e., VigiBase, from these ICSRs; NCC-PvPI was issued 56 drug safety alerts from March 2016 to June 2017. Conclusion: In India, spontaneous reporting of ADRs existed since 1998 under passive surveillance method, but there is an urgent need to initiate TSR, which is a complementary method to spontaneous reporting on these drug safety alerts for further regulatory action by Central Drugs Standard Control Organization.


  • Open Access

    Pharmacovigilance in drugs used in the treatment of drug dependence

    by Prasad Thota, Anusha Thota, Vivekanandan Kalaiselvan, Siddharth Sarkar, Gyanendra Nath Singh

    Indian J Psychiatry, Indian Journal of Psychiatry is the official publication of the Indian Psychiatric Society that considers for publication articles in all fields of Psychiatry